Calmodulin, antagonists & inhibitors
- Name
- Calmodulin, antagonists & inhibitors
- Accession Number
- DBCAT004606
- Description
Not Available
- Drugs
Drug Drug Description Prenylamine Prenylamine was withdrawn from the Canadian, US, and UK markets in 1988 due to concerns regarding cardiac arrhythmias. - Drugs & Drug Targets
Drug Target Type Prenylamine Calmodulin target Prenylamine Myosin light chain kinase 2, skeletal/cardiac muscle target Prenylamine Cytochrome P450 3A4 enzyme